256 related articles for article (PubMed ID: 33346441)
1. [Monoclonal gammopathy of renal significance: consensus of hematologists and nephrologists of Russia on the establishment of nosology, diagnostic approach and rationale for clone specific treatment].
Smirnov AV; Afanasyev BV; Poddubnaya IV; Dobronravov VA; Khrabrova MS; Zakharova EV; Nikitin EA; Lysenko Kozlovskaya LV; Bobkova IN; Rameev VV; Batyushin MM; Moiseev IS; Darskaya EI; Pirogova OV; Mendeleeva LP; Biryukova LS
Ter Arkh; 2020 Sep; 92(7):10-22. PubMed ID: 33346441
[TBL] [Abstract][Full Text] [Related]
2. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.
Leung N; Bridoux F; Batuman V; Chaidos A; Cockwell P; D'Agati VD; Dispenzieri A; Fervenza FC; Fermand JP; Gibbs S; Gillmore JD; Herrera GA; Jaccard A; Jevremovic D; Kastritis E; Kukreti V; Kyle RA; Lachmann HJ; Larsen CP; Ludwig H; Markowitz GS; Merlini G; Mollee P; Picken MM; Rajkumar VS; Royal V; Sanders PW; Sethi S; Venner CP; Voorhees PM; Wechalekar AD; Weiss BM; Nasr SH
Nat Rev Nephrol; 2019 Jan; 15(1):45-59. PubMed ID: 30510265
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal gammopathy of renal significance: Multidisciplinary approach to diagnosis and treatment.
Karam S; Haidous M; Dalle IA; Dendooven A; Moukalled N; Van Craenenbroeck A; Bazarbachi A; Sprangers B
Crit Rev Oncol Hematol; 2023 Mar; 183():103926. PubMed ID: 36736510
[TBL] [Abstract][Full Text] [Related]
4. Updates in Plasma Cell Dyscrasias and Related Monoclonal Immunoglobulin-Mediated Renal Disease.
Midha S; Nadeem O; Selamet U
Semin Nephrol; 2022 Nov; 42(6):151352. PubMed ID: 37257390
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal Gammopathy of Renal Significance (MGRS): Prospects for Treatment in Integrated Chinese and Western Medicine.
Li JP; Du YT; Li S; Rao XR
Chin J Integr Med; 2021 Sep; 27(9):643-648. PubMed ID: 34105098
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity.
Ciocchini M; Arbelbide J; Musso CG
Int Urol Nephrol; 2017 Dec; 49(12):2171-2175. PubMed ID: 28425076
[TBL] [Abstract][Full Text] [Related]
7. [Classification and Management of MGRS Related Diseases].
Angioi A; Lepori N; Derudas D; Floris M; Mascia G; Cabiddu G; Pani A
G Ital Nefrol; 2023 Oct; 40(Suppl 81):. PubMed ID: 38007837
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal gammopathy of renal significance: Spectrum of diseases and approach to a case.
Tewari R; Chatterjee T; Mendonca S; Dogra M; Pramanik SK; Yanamandra U
Saudi J Kidney Dis Transpl; 2021; 32(2):298-306. PubMed ID: 35017322
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology and management of monoclonal gammopathy of renal significance.
Jain A; Haynes R; Kothari J; Khera A; Soares M; Ramasamy K
Blood Adv; 2019 Aug; 3(15):2409-2423. PubMed ID: 31409583
[TBL] [Abstract][Full Text] [Related]
10. C3 Glomerulonephritis Associated with Monoclonal Gammopathy of Renal Significance.
Gomes-Alves I; Castro-Ferreira I
Acta Med Port; 2021 May; 34(5):372-377. PubMed ID: 33819437
[TBL] [Abstract][Full Text] [Related]
11. Kidney Histopathologic Spectrum and Clinical Indicators Associated with MGRS.
Yong ZH; Yu XJ; Liu JX; Zhou FD; Wang SX; Zhao MH
Clin J Am Soc Nephrol; 2022 Apr; 17(4):527-534. PubMed ID: 35210280
[TBL] [Abstract][Full Text] [Related]
12. [Monoclonal gammapathy of renal significance (MGRS) at the current state: terminology, diagnosis and treatment].
Lysenko Kozlovskaya LV; Rameev VV; Androsova TV
Ter Arkh; 2020 Jul; 92(6):15-22. PubMed ID: 33346488
[TBL] [Abstract][Full Text] [Related]
13. The Role of Bone Marrow Biopsy Evaluation in the Workup for Monoclonal Gammopathy of Renal Significance: A Diagnosis of Exclusion.
Metcalf BD; Huang J; Kanaan HD; Abukhaled J; Li W; Samarapungavan D; Zarouk S; Zhang PL
Arch Pathol Lab Med; 2024 Mar; 148(3):e57-e62. PubMed ID: 37787408
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options.
Amaador K; Peeters H; Minnema MC; Nguyen TQ; Dendooven A; Vos JMI; Croockewit AJ; van de Donk NWCJ; Jacobs JFM; Wetzels JFM; Sprangers B; Abrahams AC
Neth J Med; 2019 Sep; 77(7):243-254. PubMed ID: 31582582
[TBL] [Abstract][Full Text] [Related]
15. Rate and Predictors of Finding Monoclonal Gammopathy of Renal Significance (MGRS) Lesions on Kidney Biopsy in Patients with Monoclonal Gammopathy.
Klomjit N; Leung N; Fervenza F; Sethi S; Zand L
J Am Soc Nephrol; 2020 Oct; 31(10):2400-2411. PubMed ID: 32747354
[TBL] [Abstract][Full Text] [Related]
16. The clinical implication of monoclonal gammopathies: monoclonal gammopathy of undetermined significance and of renal significance.
Batko K; Malyszko J; Jurczyszyn A; Vesole DH; Gertz MA; Leleu X; Suska A; Krzanowski M; Sułowicz W; Malyszko JS; Krzanowska K
Nephrol Dial Transplant; 2019 Sep; 34(9):1440-1452. PubMed ID: 30169860
[TBL] [Abstract][Full Text] [Related]
17. Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance.
Sprangers B; Hegenbart U; Wetzels JFM
Transplantation; 2023 May; 107(5):1056-1068. PubMed ID: 36584374
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal gammopathies of renal significance.
Caravaca-Fontán F; Gutiérrez E; Delgado Lillo R; Praga M
Nefrologia; 2017; 37(5):465-477. PubMed ID: 28946960
[TBL] [Abstract][Full Text] [Related]
19. Lambda light chain-induced monoclonal gammopathy of renal significance, manifesting with Fanconi Syndrome and osteomalacia.
Gutiérrez-Peredo GB; Filho JCBO; Montaño-Castellón I; Gutiérrez-Peredo AJ; Crusoé EQ; Gusmao-Flores D
BMC Nephrol; 2022 Aug; 23(1):278. PubMed ID: 35945525
[TBL] [Abstract][Full Text] [Related]
20. How I treat monoclonal gammopathy of renal significance (MGRS).
Fermand JP; Bridoux F; Kyle RA; Kastritis E; Weiss BM; Cook MA; Drayson MT; Dispenzieri A; Leung N;
Blood; 2013 Nov; 122(22):3583-90. PubMed ID: 24108460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
